Solasta Ventures
Home Approach Portfolio
News Team Hatchery Contact
HomeApproachPortfolio
Solasta Ventures
NewsTeamHatcheryContact
Intellia Therapeutics and ReCode Therapeutics Announce Strategic Collaboration to Develop Novel Gene Editing Therapies for Cystic Fibrosis
Nia JulianFebruary 15, 2024
Facebook0 Twitter Pinterest0 0 Likes
Previous

Axonis Therapeutics Announces $115 Million Series A Financing

Nia JulianOctober 30, 2024
Next

EvolveImmune Therapeutics Provides Corporate and Program Update Highlighted by Closing of $37 Million Financing

Nia JulianDecember 21, 2023

© 2020 Solasta Ventures. All Rights Reserved.